PDUFA bill carries device language
This article was originally published in The Gray Sheet
Executive Summary
Prescription Drug User Fee Act reauthorization legislation, set for markup April 18 in the Senate Health, Education, Labor & Pensions Committee, would establish a publicly accessible database of all postmarket surveillances and studies of PMA-approved and 510(k)-cleared medical devices. The legislative language comes after CDRH has already voluntarily launched a public 1Web site tracking postmarket study progress (2"The Gray Sheet" April 2, 2007, p. 26). The bill also includes language, originally introduced by Senator Chris Dodd, D-Conn., last month, that would link pediatric device innovators with funding sources, allow profit for humanitarian-device-exempted devices and mandate postmarket surveillance studies for pediatric devices (3"The Gray Sheet" April 2, 2007, p. 25). In addition, the legislation formally encourages reauthorization of the Medical Device User Fee and Modernization Act of 2002, which, like the drug user fee program, needs to be reauthorized before Sept. 30 when it is set to expire...
You may also be interested in...
No More Secrets: CDRH Post-Approval Study Web Site Goes Live April 6
A public Web site tracking device companies' progress on FDA-required post-approval studies is scheduled to go live April 6
Dodd Aims For Quick Passage Of Pediatric Device Legislation
Sen. Christopher Dodd, D-Conn., is pushing for quick action on legislation to provide incentives for the development of pediatric medical devices
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.